MRI in sarcoglycanopathies: a large international cohort study

Giorgio Tasca; Mauro Monforte; Jordi Díaz-Manera; Giacomo Brisca; Claudio Semplicini; Adele D'Amico; Fabiana Fattori; Anna Pichiecchio; Angela Berardinelli; Lorenzo Maggi; Elio Maccagnano; Nicoline Løkken; Chiara Marini-Bettolo; Francina Munell; Angel Sanchez; Nahla Alshaikh; Nicol C. Voermans; Jahannaz Dastgir; Dmitry Vlodavets; Jana Haberlová; Gianmichele Magnano; Maggie C. Walter; Susana Quijano-Roy; Robert Yves Carlier; Baziel G.M. van Engelen; John Vissing; Volker Straub; Carsten G. Bönnemann; Eugenio Mercuri; Francesco Muntoni; Elena Pegoraro; Enrico Bertini; Bjarne Udd; Enzo Ricci; Claudio Bruno

doi:10.1136/jnnp-2017-316736

MRI in sarcoglycanopathies: a large international cohort study

Giorgio Tasca, Mauro Monforte, Jordi Díaz-Manera, Giacomo Brisca, Claudio Semplicini, Adele D'Amico, Fabiana Fattori, Anna Pichiecchio, Angela Berardinelli, Lorenzo Maggi, Elio Maccagnano, Nicoline Løkken, Chiara Marini-Bettolo, Francina Munell, Angel Sanchez, Nahla Alshaikh, Nicol C. Voermans, Jahannaz Dastgir, Dmitry Vlodavets, Jana HaberlováGianmichele Magnano, Maggie C. Walter, Susana Quijano-Roy, Robert Yves Carlier, Baziel G.M. van Engelen, John Vissing, Volker Straub, Carsten G. Bönnemann, Eugenio Mercuri, Francesco Muntoni, Elena Pegoraro, Enrico Bertini, Bjarne Udd, Enzo Ricci, Claudio Bruno

26 Citations (Scopus)

Abstract

OBJECTIVES: To characterise the pattern and spectrum of involvement on muscle MRI in a large cohort of patients with sarcoglycanopathies, which are limb-girdle muscular dystrophies (LGMD2C-2F) caused by mutations in one of the four genes coding for muscle sarcoglycans.

METHODS: Lower limb MRI scans of patients with LGMD2C-2F, ranging from severe childhood variants to milder adult-onset forms, were collected in 17 neuromuscular referral centres in Europe and USA. Muscle involvement was evaluated semiquantitatively on T1-weighted images according to a visual score, and the global pattern was assessed as well.

RESULTS: Scans from 69 patients were examined (38 LGMD2D, 18 LGMD2C, 12 LGMD2E and 1 LGMD2F). A common pattern of involvement was found in all the analysed scans irrespective of the mutated gene. The most and earliest affected muscles were the thigh adductors, glutei and posterior thigh groups, while lower leg muscles were relatively spared even in advanced disease. A proximodistal gradient of involvement of vasti muscles was a consistent finding in these patients, including the most severe ones.

CONCLUSIONS: Muscle involvement on MRI is consistent in patients with LGMD2C-F and can be helpful in distinguishing sarcoglycanopathies from other LGMDs or dystrophinopathies, which represent the most common differential diagnoses. Our data provide evidence about selective susceptibility or resistance to degeneration of specific muscles when one of the sarcoglycans is deficient, as well as preliminary information about progressive involvement of the different muscles over time.

Original language	English
Journal	Journal of neurology, neurosurgery, and psychiatry
Volume	89
Issue number	1
Pages (from-to)	72-77
Number of pages	6
ISSN	0022-3050
DOIs	https://doi.org/10.1136/jnnp-2017-316736
Publication status	Published - Jan 2018

Access to Document

10.1136/jnnp-2017-316736

Cite this

Tasca, G., Monforte, M., Díaz-Manera, J., Brisca, G., Semplicini, C., D'Amico, A., Fattori, F., Pichiecchio, A., Berardinelli, A., Maggi, L., Maccagnano, E., Løkken, N., Marini-Bettolo, C., Munell, F., Sanchez, A., Alshaikh, N., Voermans, N. C., Dastgir, J., Vlodavets, D., ... Bruno, C. (2018). MRI in sarcoglycanopathies: a large international cohort study. Journal of neurology, neurosurgery, and psychiatry, 89(1), 72-77. https://doi.org/10.1136/jnnp-2017-316736

Tasca, G, Monforte, M, Díaz-Manera, J, Brisca, G, Semplicini, C, D'Amico, A, Fattori, F, Pichiecchio, A, Berardinelli, A, Maggi, L, Maccagnano, E, Løkken, N, Marini-Bettolo, C, Munell, F, Sanchez, A, Alshaikh, N, Voermans, NC, Dastgir, J, Vlodavets, D, Haberlová, J, Magnano, G, Walter, MC, Quijano-Roy, S, Carlier, RY, van Engelen, BGM, Vissing, J, Straub, V, Bönnemann, CG, Mercuri, E, Muntoni, F, Pegoraro, E, Bertini, E, Udd, B, Ricci, E & Bruno, C 2018, 'MRI in sarcoglycanopathies: a large international cohort study', Journal of neurology, neurosurgery, and psychiatry, vol. 89, no. 1, pp. 72-77. https://doi.org/10.1136/jnnp-2017-316736

@article{3694bc69eb5e4bd98efadb17023acdfc,

title = "MRI in sarcoglycanopathies: a large international cohort study",

abstract = "OBJECTIVES: To characterise the pattern and spectrum of involvement on muscle MRI in a large cohort of patients with sarcoglycanopathies, which are limb-girdle muscular dystrophies (LGMD2C-2F) caused by mutations in one of the four genes coding for muscle sarcoglycans.METHODS: Lower limb MRI scans of patients with LGMD2C-2F, ranging from severe childhood variants to milder adult-onset forms, were collected in 17 neuromuscular referral centres in Europe and USA. Muscle involvement was evaluated semiquantitatively on T1-weighted images according to a visual score, and the global pattern was assessed as well.RESULTS: Scans from 69 patients were examined (38 LGMD2D, 18 LGMD2C, 12 LGMD2E and 1 LGMD2F). A common pattern of involvement was found in all the analysed scans irrespective of the mutated gene. The most and earliest affected muscles were the thigh adductors, glutei and posterior thigh groups, while lower leg muscles were relatively spared even in advanced disease. A proximodistal gradient of involvement of vasti muscles was a consistent finding in these patients, including the most severe ones.CONCLUSIONS: Muscle involvement on MRI is consistent in patients with LGMD2C-F and can be helpful in distinguishing sarcoglycanopathies from other LGMDs or dystrophinopathies, which represent the most common differential diagnoses. Our data provide evidence about selective susceptibility or resistance to degeneration of specific muscles when one of the sarcoglycans is deficient, as well as preliminary information about progressive involvement of the different muscles over time.",

author = "Giorgio Tasca and Mauro Monforte and Jordi D{\'i}az-Manera and Giacomo Brisca and Claudio Semplicini and Adele D'Amico and Fabiana Fattori and Anna Pichiecchio and Angela Berardinelli and Lorenzo Maggi and Elio Maccagnano and Nicoline L{\o}kken and Chiara Marini-Bettolo and Francina Munell and Angel Sanchez and Nahla Alshaikh and Voermans, {Nicol C.} and Jahannaz Dastgir and Dmitry Vlodavets and Jana Haberlov{\'a} and Gianmichele Magnano and Walter, {Maggie C.} and Susana Quijano-Roy and Carlier, {Robert Yves} and {van Engelen}, {Baziel G.M.} and John Vissing and Volker Straub and B{\"o}nnemann, {Carsten G.} and Eugenio Mercuri and Francesco Muntoni and Elena Pegoraro and Enrico Bertini and Bjarne Udd and Enzo Ricci and Claudio Bruno",

year = "2018",

month = jan,

doi = "10.1136/jnnp-2017-316736",

language = "English",

volume = "89",

pages = "72--77",

journal = "Journal of neurology, neurosurgery, and psychiatry",

issn = "0022-3050",

publisher = "B M J Group",

number = "1",

}

TY - JOUR

T1 - MRI in sarcoglycanopathies

T2 - a large international cohort study

AU - Tasca, Giorgio

AU - Monforte, Mauro

AU - Díaz-Manera, Jordi

AU - Brisca, Giacomo

AU - Semplicini, Claudio

AU - D'Amico, Adele

AU - Fattori, Fabiana

AU - Pichiecchio, Anna

AU - Berardinelli, Angela

AU - Maggi, Lorenzo

AU - Maccagnano, Elio

AU - Løkken, Nicoline

AU - Marini-Bettolo, Chiara

AU - Munell, Francina

AU - Sanchez, Angel

AU - Alshaikh, Nahla

AU - Voermans, Nicol C.

AU - Dastgir, Jahannaz

AU - Vlodavets, Dmitry

AU - Haberlová, Jana

AU - Magnano, Gianmichele

AU - Walter, Maggie C.

AU - Quijano-Roy, Susana

AU - Carlier, Robert Yves

AU - van Engelen, Baziel G.M.

AU - Vissing, John

AU - Straub, Volker

AU - Bönnemann, Carsten G.

AU - Mercuri, Eugenio

AU - Muntoni, Francesco

AU - Pegoraro, Elena

AU - Bertini, Enrico

AU - Udd, Bjarne

AU - Ricci, Enzo

AU - Bruno, Claudio

PY - 2018/1

Y1 - 2018/1

N2 - OBJECTIVES: To characterise the pattern and spectrum of involvement on muscle MRI in a large cohort of patients with sarcoglycanopathies, which are limb-girdle muscular dystrophies (LGMD2C-2F) caused by mutations in one of the four genes coding for muscle sarcoglycans.METHODS: Lower limb MRI scans of patients with LGMD2C-2F, ranging from severe childhood variants to milder adult-onset forms, were collected in 17 neuromuscular referral centres in Europe and USA. Muscle involvement was evaluated semiquantitatively on T1-weighted images according to a visual score, and the global pattern was assessed as well.RESULTS: Scans from 69 patients were examined (38 LGMD2D, 18 LGMD2C, 12 LGMD2E and 1 LGMD2F). A common pattern of involvement was found in all the analysed scans irrespective of the mutated gene. The most and earliest affected muscles were the thigh adductors, glutei and posterior thigh groups, while lower leg muscles were relatively spared even in advanced disease. A proximodistal gradient of involvement of vasti muscles was a consistent finding in these patients, including the most severe ones.CONCLUSIONS: Muscle involvement on MRI is consistent in patients with LGMD2C-F and can be helpful in distinguishing sarcoglycanopathies from other LGMDs or dystrophinopathies, which represent the most common differential diagnoses. Our data provide evidence about selective susceptibility or resistance to degeneration of specific muscles when one of the sarcoglycans is deficient, as well as preliminary information about progressive involvement of the different muscles over time.

AB - OBJECTIVES: To characterise the pattern and spectrum of involvement on muscle MRI in a large cohort of patients with sarcoglycanopathies, which are limb-girdle muscular dystrophies (LGMD2C-2F) caused by mutations in one of the four genes coding for muscle sarcoglycans.METHODS: Lower limb MRI scans of patients with LGMD2C-2F, ranging from severe childhood variants to milder adult-onset forms, were collected in 17 neuromuscular referral centres in Europe and USA. Muscle involvement was evaluated semiquantitatively on T1-weighted images according to a visual score, and the global pattern was assessed as well.RESULTS: Scans from 69 patients were examined (38 LGMD2D, 18 LGMD2C, 12 LGMD2E and 1 LGMD2F). A common pattern of involvement was found in all the analysed scans irrespective of the mutated gene. The most and earliest affected muscles were the thigh adductors, glutei and posterior thigh groups, while lower leg muscles were relatively spared even in advanced disease. A proximodistal gradient of involvement of vasti muscles was a consistent finding in these patients, including the most severe ones.CONCLUSIONS: Muscle involvement on MRI is consistent in patients with LGMD2C-F and can be helpful in distinguishing sarcoglycanopathies from other LGMDs or dystrophinopathies, which represent the most common differential diagnoses. Our data provide evidence about selective susceptibility or resistance to degeneration of specific muscles when one of the sarcoglycans is deficient, as well as preliminary information about progressive involvement of the different muscles over time.

U2 - 10.1136/jnnp-2017-316736

DO - 10.1136/jnnp-2017-316736

M3 - Journal article

C2 - 28889091

AN - SCOPUS:85039991338

SN - 0022-3050

VL - 89

SP - 72

EP - 77

JO - Journal of neurology, neurosurgery, and psychiatry

JF - Journal of neurology, neurosurgery, and psychiatry

IS - 1

ER -

MRI in sarcoglycanopathies: a large international cohort study

Abstract

Access to Document

Fingerprint

Cite this